✦ LIBER ✦

KI67 and p53 are not predictive of tumor response or survival with trastuzumab-based therapy in metastatic breast cancer patients (pts) with her2/neu-overexpression

✍ Scribed by A. Schneeweiss; F. Lenz; F. Beldermann; M. Geberth; R. Goerner; P. Sinn; H.-J. Strittmatter; G. Bastert

Book ID: 117658512
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 171 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81149-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2/neu and EGFR tyrosine kinase activ

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man

Clinical utility of serum HER2/neu in mo

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

✍ Francisco J Esteva, Carol D Cheli, Herbert Fritsche… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 195 KB

Phosphorylated HER-2 tyrosine kinase and

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

✍ Rosa Giuliani; Virginie Durbecq; Angelo Di Leo; Marianne Paesmans; Denis Larsimo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 636 KB

Clinical significance of p95HER2 overexp

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

✍ Tural, D; Serdengecti, S; Demirelli, F; Öztürk, T; İlvan, S; Turna, H; Özgüroglu 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 894 KB